What The Newest Salbutamol Study Means For Froome

What the newest salbutamol study means for Froome

Peter Stuart 8 May 2018 Froome’s salbutamol defence grows stronger with new study that claims WADA’s test for salbutamol is fundamentally flawed A recent study has added further strength to Chris Froome’s defence against a possible sanction over an Adverse Analytical Finding (AAF) for excessive levels of salbutamol in his urine, by claiming the testing system is fundamentally flawed. Froome exceeded the permitted limit of salbutamol in his urine, set at 1,000ng/ml. Froome registered a concentration of 2,000ng/ml. The 1,000ng/ml limit is intended to reflect a maximum dosage of 1,600 micrograms per 24 hours. It is accepted that the relationship between the dosage and the reading is not a linear one (according to this study , for instance) though it has been believed that a permitted dosage could not lead to an adverse finding. Initially reported by The Times , a study published in the British Journal of Clinical Pharmacology ...

Read on Cyclist


More Like This

Card image cap

Chris Froome's salbutamol defence boosted by scientific study

View
Card image cap

WADA will not appeal UCI verdict on Chris Froome salbutamol case

View
Card image cap

Research paper raises questions about Salbutamol tests, may aid Froome’s defence

View
Card image cap

Petacchi feels vindicated by resolution of Chris Froome case

View
Card image cap

Piss take: Researchers defend study claiming Salbutamol urine test is flawed

View
Card image cap

UK Anti-Doping data a blow to Chris Froome's salbutamol defence

View
Card image cap

Analysis: WADA appears to contradict UCI over Froome case decision

View
Card image cap

WADA decides against Froome anti-doping appeal

View
Card image cap

UCI says no reasoned decision will be released for Froome case, elaborates on related topics

View
Card image cap

Opinion: Why WADA and the UCI’s handling of the Froome case is damaging to sport

View